Proceedings of the International scientific and practical conference ― Cambridge Science and Education Conference‖ (February 23-25, 2026) / Publisher website: www.naukainfo.com. – Cambridge, United Kingdom, 2026. - 289 p.

234 8. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188. doi:10.1093/eurheartj/ehz455 9. Bittner V. Non-high-density lipoprotein cholesterol and cardiovascular disease. Curr Opin Lipidol. 2003;14(4):367-371. doi:10.1097/00041433-200308000- 00005 10. Zevin EL, Peterson AL, Dodge A, Zhang X, Carrel AL. Low HDL-C is a non- fasting marker of insulin resistance in children. J Pediatr Endocrinol Metab. 2022;35(7):890-894. Published 2022 Jun 2. doi:10.1515/jpem-2021-0751 11. Brunner FJ, Waldeyer C, Ojeda F, et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet. 2019;394(10215):2173- 2183. doi:10.1016/S0140-6736(19)32519-X 12. Duan M, Zhao X, Li S, et al. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001-2018. Cardiovasc Diabetol. 2024;23(1):243. Published 2024 Jul 10. doi:10.1186/s12933-024-02334-8 13. Azarpazhooh MR, Najafi F, Darbandi M, Kiarasi S, Oduyemi T, Spence JD. Triglyceride/High-Density Lipoprotein Cholesterol Ratio: A Clue to Metabolic Syndrome, Insulin Resistance, and Severe Atherosclerosis. Lipids. 2021;56(4):405-412. doi:10.1002/lipd.12302 14. Li J, Meng Q, Fu Y, et al. Novel insights: Dynamic foam cells derived from the macrophage in atherosclerosis. J Cell Physiol. 2021;236(9):6154-6167. doi:10.1002/jcp.30300 15. Kronenberg F, Mora S, Stroes ESG, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43(39):3925-3946. doi:10.1093/eurheartj/ehac361 16. Rosenson RS, Tate AM, Grushko OG, et al. Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic